Replacing, reducing and refining the use of animals in tuberculosis vaccine 1 research

Replacing, reducing and refining the use of animals in tuberculosis vaccine 1 research

Tuberculosis (TB) remains a serious global health threat and an improved vaccine is urgently needed. New candidate TB vaccines are tested using preclinical animal models such as mice, guinea pigs, cattle and non-human primates. Animals are routinely infected with virulent Mycobacterium tuberculos...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Tanner, R, McShane, H
Formaat:	Journal article
Gepubliceerd in:	ALTEX Edition 2016

Gelijkaardige items

Vaccines for tuberculosis
door: McShane, H
Gepubliceerd in: (2013)

Reducing, refining and replacing the use of animals in toxicity testing /
door: Allen, David G. (David Glenwood), et al.
Gepubliceerd in: (2014)

Vaccine strategies against tuberculosis
door: H McShane
Gepubliceerd in: (2009-03-01)

Insights and challenges in tuberculosis vaccine development
door: McShane, H
Gepubliceerd in: (2019)

Tuberculosis vaccines: beyond bacille Calmette–Guérin
door: McShane, H
Gepubliceerd in: (2011)

Tuberculosis vaccines: Beyond bacilli Calmette-Guérin
door: McShane, H
Gepubliceerd in: (2011)

Tuberculosis vaccines: Progress and challenges
door: Checkley, A, et al.
Gepubliceerd in: (2011)

Improving tuberculosis vaccine trial efficiency: a tough nut to crack
door: McShane, H
Gepubliceerd in: (2023)

Why don’t we have an effective tuberculosis vaccine yet?
door: Davenne, T, et al.
Gepubliceerd in: (2016)

Editorial: 3Rs approach (replace, reduce and refine animal models) to improve preclinical research
door: Laura Calvillo
Gepubliceerd in: (2022-10-01)

Clinical testing of tuberculosis vaccine candidates
door: Hatherill, M, et al.
Gepubliceerd in: (2016)

The VALIDATE network: accelerating vaccine development for tuberculosis, leishmaniasis, melioidosis and leprosy
door: Vermaak, S, et al.
Gepubliceerd in: (2023)

A Novel Dental Caries Model Replacing, Refining, and Reducing Animal Sacrifice
door: Amit Wolfoviz-Zilberman, et al.
Gepubliceerd in: (2021-08-01)

Dual neonate vaccine platform against HIV-1 and M. tuberculosis.
door: Hopkins, R, et al.
Gepubliceerd in: (2011)

Tuberculosis vaccines in the era of Covid-19 - what is taking us so long?
door: Dockrell, HM, et al.
Gepubliceerd in: (2022)

Factors influencing the higher incidence of tuberculosis among migrants and ethnic minorities in the UK
door: Hayward, S, et al.
Gepubliceerd in: (2018)

Human and Bovine Tuberculosis
door: McShane, H
Gepubliceerd in: (2016)

Mucosal delivery of tuberculosis vaccines: a review of current approaches and challenges
door: Stylianou, E, et al.
Gepubliceerd in: (2019)

A review of preclinical animal models utilised for TB vaccine evaluation in the context of recent human efficacy data.
door: McShane, H, et al.
Gepubliceerd in: (2014)

A review of preclinical animal models utilised for TB vaccine evaluation in the context of recent human efficacy data
door: McShane, H, et al.
Gepubliceerd in: (2014)

Vaccination against tuberculosis: how can we better BCG?
door: Pitt, J, et al.
Gepubliceerd in: (2013)

Vaccination against tuberculosis: How can we better BCG?
door: Pitt, J, et al.
Gepubliceerd in: (2013)

Tuberculosis vaccines in the era of Covid-19 – what is taking us so long?
door: Hazel M. Dockrell, et al.
Gepubliceerd in: (2022-05-01)

The humoral immune response to BCG vaccination
door: Tanner, R, et al.
Gepubliceerd in: (2019)

Effects of MVA85A vaccine on tuberculosis challenge in animals: systematic review
door: Mcshane, H, et al.
Gepubliceerd in: (2016)

Survey of Canadian animal-based researchers' views on the Three Rs: replacement, reduction and refinement.
door: Nicole Fenwick, et al.
Gepubliceerd in: (2011-01-01)

Vaccine strategies against tuberculosis.
door: Mcshane, H
Gepubliceerd in: (2009)

Tuberculosis vaccines in clinical trials.
door: Rowland, R, et al.
Gepubliceerd in: (2011)

The Sharing Experimental Animal Resources, Coordinating Holdings (SEARCH) Framework: Encouraging Reduction, Replacement, and Refinement in Animal Research.
door: Bethny Morrissey, et al.
Gepubliceerd in: (2017-01-01)

Dual neonate vaccine platform against HIV-1 and M. tuberculosis.
door: Richard Hopkins, et al.
Gepubliceerd in: (2011-01-01)

Controlled human infection models: is it really feasible to give people tuberculosis?
door: McShane, H
Gepubliceerd in: (2020)

Immunogenicity of the tuberculosis vaccine MVA85A is reduced by coadministration with EPI vaccines in a randomized controlled trial in Gambian infants.
door: Ota, M, et al.
Gepubliceerd in: (2011)

Developing an improved vaccine against tuberculosis.
door: Mcshane, H
Gepubliceerd in: (2004)

Local pulmonary immunological biomarkers in tuberculosis
door: Morrison, H, et al.
Gepubliceerd in: (2021)

Refining animal research: The Animal Study Registry.
door: Bettina Bert, et al.
Gepubliceerd in: (2019-10-01)

Tuberculosis vaccines: progress and challenges.
door: Checkley, A, et al.
Gepubliceerd in: (2011)

Tuberculosis vaccines: present and future.
door: Minassian, A, et al.
Gepubliceerd in: (2008)

Challenges in developing a controlled human tuberculosis challenge model
door: Jackson, S, et al.
Gepubliceerd in: (2022)

In vitro mycobacterial growth inhibition assays: A tool for the assessment of protective immunity and evaluation of tuberculosis vaccine efficacy
door: Mcshane, H, et al.
Gepubliceerd in: (2017)

Refinement of Animal Experiments: Replacing Traumatic Methods of Laboratory Animal Marking with Non-Invasive Alternatives
door: Ilya Klabukov, et al.
Gepubliceerd in: (2023-11-01)